| I N TR ODU C TI ON
Cervical spondylomyelopathy (CSM) a common disease of the cervical vertebral column in large and giant breed dogs, particularly Doberman Pinschers and Great Danes. 1, 2 Gait abnormalities often are 1 of the first signs noted in dogs with CSM and are observed as a slowly progressive pelvic limb ataxia or "wobbling" of the pelvic limbs. 1, 3 Thoracic limb abnormalities may manifest themselves as variable degrees of ataxia in combination with a short, stilted gait. 1, 3, 4 The disease is secondary to a collection of disorders affecting primarily the caudal cervical vertebrae and intervertebral discs resulting in clinical signs of spinal cord or nerve root compression or both including neurologic deficits, cervical hyperesthesia, or both. 3, 5 The cause of the spinal cord compression often is multifactorial and can be caused by vertebral canal stenosis (relative or absolute), intervertebral disc protrusion, or hypertrophy of the ligamentum flavum. 1 Based on the multifactorial pathogenesis of this disease process, treatment recommendations are highly variable. Thus, the standard method for evaluating response to treatment is based on subjective interpretation of both the clinician and client's perception. For this reason, objective parameters are needed that can be correlated to clinical findings.
Kinematic and kinetic gait analyses are being used more frequently in veterinary medicine. Specifically, gait analysis has been used for evaluation of orthopedic diseases including cranial cruciate ligament disease, hip dysplasia, and treatment outcomes after surgical repair of these conditions. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Gait analysis also has been used in the evaluation of neurologic diseases in animal models, including dogs, horses, and rodents. [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] More recently, these techniques were applied in evaluating dogs with CSM. 21, 22, 30 In human medicine, gait analysis has been used routinely in the evaluation of neurologic conditions, including cervical spondylotic myelopathy, the equivalent of CSM in humans. [31] [32] [33] [34] [35] [36] [37] These techniques have been used to correlate findings on magnetic resonance imaging (MRI) with clinical signs and to determine outcomes after surgery. 32, 34 A recent study evaluated both kinetic and kinematic parameters in the pelvic limbs in a group of control dogs and dogs that underwent a thoracolumbar hemilaminectomy for disc disease. 26 Although this study found significant changes between the groups, it did not correlate the abnormalities in these gait parameters with clinical neurologic status.
The purpose of our study was to compare selected force plate kinetic and digital video motion capture kinematic parameters before and after medical or surgical treatment and to correlate these parameters with clinical signs to use as markers of outcome. We hypothesized that certain kinetic and kinematic parameters such as peak vertical force (PVF), thoracic and pelvic limb distances, truncal sway (ie, spinal angles), and thoracic limb stride duration would be significantly different between the initial and post-treatment follow-up gait analyses. We also hypothesized that these parameters would be correlated with clinical outcome.
| M A TER I A LS A N D M ETH OD S

| Animals
Eight client-owned mature Doberman Pinscher dogs were prospectively enrolled. The dogs were part of a previous study for which baseline data was presented in 2 previous studies. 21, 22 The study was conducted in accordance with the guidelines and approval of the Clini- Three-dimensional motion capture also was performed as previously described. 21 All dogs were fitted with a Lycra (Invista, Wichita, Kansas) bodysuit and 32 reflective markers were applied representing specific anatomic landmarks of the head, trunk, and limbs. Three- were the angles made between these 2 vectors in the y-plane. Lastly, hip drop, or pelvic limb height difference was calculated using the difference between maximum and minimum distance from the marker on the greater trochanter and the hind paw in the x-plane.
| Statistical analysis
All data for the 3-D motion capture were cleaned and exported using 
| Gait analysis
The mean number of valid passes collected during kinetic gait analysis Detailed results of the kinetic and kinematic gait analysis are presented in Tables 1 and 2 . Maximum and minimum thoracic limb distance was found to be larger after treatment with the maximum thoracic distance increasing from 190.1 to 203.1 mm and the minimum increasing from 130.2 to 140.6 mm. However, the differences were not found to be statistically significant (P 5 .08; P 5 .110, respectively). Maximum truncal sway to the right was found to be significantly smaller after treatment (P < .001) but no other changes in truncal sway were significantly different (Table 1) . When comparing the means from each limb of all dogs with force plate analysis, PVF was significantly different in all dogs after treatment (P 5 .049). When using the mean values from all limbs combined for all dogs before and after treatment the difference between PVF was significantly larger (P 5 .027; Table 2 ). The other parameters analyzed were nonsignificant. When correlating clinical outcome to gait analysis parameters, no predictor variable approached statistically significant correlation with recovery.
| D ISC USSION
Our study was designed to use specific kinetic and kinematic gait parameters to detect consistent differences in Doberman Pinchers with CSM after medical or surgical treatment and to correlate these findings with clinical status. The results supported our hypothesis that PVF would be significantly different from initial presentation to followup. We found PVF to be significantly larger after treatment and it remained higher in the thoracic limbs. In patients suffering from orthopedic disease, a lower PVF indicates lameness or impaired function.
Therefore, an increase in PVF in our patients after treatment would be indicative of improvement. 38 This finding could indicate potential improvement in strength in our patient population. It was also noted that PVF in the thoracic limbs remained higher than in the pelvic limbs, even after treatment. This finding is not surprising because it is generally assumed that dogs carry approximately 60% of their body weight in the thoracic limbs and approximately 40% in the pelvic limbs. 39 We also found our hypothesis was partially correct in regard to truncal sway because this parameter was noted to be smaller after treatment. It is interesting that truncal sway to the right was improved but the truncal sway to the left was not significantly different. This finding may be a consequence of the fact that in our patient population, 50% (4/8) of dogs were neurologically more affected on the right side, whereas in the remaining dogs, 3 were worse on the left and 1 did not show lateralization. Additionally, in those dogs that had lateralized compression on MRI, 75% (3/4) had more severe compression on the right. This finding may not be unusual because mild asymmetric signs are seen in approximately 50% of dogs with CSM. 1, 40 In 1 study, it was observed that Dachshunds suffering from thoracolumbar disc disease had more pronounced asymmetric changes on the affected side of the body and it was theorized that patients with uncoordinated gait may be falling to the more affected side or limb because of lack of control on that side. 26 Another study also showed greater thoracolumbar lateral angulation in the direction of the affected limb in dogs without visually detectable lameness. 41 A finding we did not expect was the increased flexion of the right stifle at follow-up. The decreased flexion on presentation is likely explained by spastic paresis, but we would expect an improvement in both pelvic limbs. The explanation again may be associated with the fact that half of the dogs were affected on the right side and also may be explained by another study in which dogs affected with myelopathic disease tend to fall towards 1 side more than the other. 26 Therefore, reduction in truncal sway actually may indicate an improvement in mild, asymmetric ataxia, and the increased stifle flexion may indicate mild improvement in weakness.
The other explanation for the finding of asymmetrical truncal sway (right versus the left) could be that of soft tissue artifact (STA). Soft tissue artifact is a common source of error in gait analysis of humans and horses by and is caused by movement of the skin being recorded instead of the underlying skeletal structures when using skin markers. 
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Algorithms have been proposed to correct for STA in horses but none exist yet for dogs. 42 We were not able to show a correlation in clinical outcome with the gait analysis parameters. Despite the fact that a correlation was not identified, all 3 dogs in which clinical improvement was noted showed corresponding changes in the kinetic and kinematic parameters. All 3 dogs experienced a decrease in truncal sway and an increase in right stifle flexion. Because of small sample size, we cannot draw a conclusion from these results, but they do suggest further investigation, especially into using truncal sway and spine angles as outcome measures.
This finding also is similar to that of another study in which pelvic sway range of motion was found to be a more sensitive indicator of myelopathy as compared to pelvic limb joint range of motion. 26 The reliability of 3-D gait analysis is evaluated in multiple ways, 1 of which is performing multiple walking trials within a single session.
The variability among these trials is classified as "intrinsic" and reflects the inherent variation within either unimpaired individuals or those with underlying pathology. Intrinsic variations reflect intraindividual variations that arise naturally, either from trial-to-trial or subject-tosubject variability. Usually, these variations can be overcome by collection of data from many walking trials during the same session. [43] [44] [45] In our study, multiple trials and observations were performed for each patient for both the kinetic and kinematic gait analysis with an average of 4.5 valid trials and 22.75 observations, respectively. Extrinsic factors also account for variability and typically are from procedural errors, with marker placement being a key factor. 43 A main issue with the use of skin markers is accurate and repeatable placement of the markers.
One study found that accurate and reproducible marker placement was difficult in dogs because it required the dogs in the study to stand completely still in a neutral position. 26 In our study, Lycra body suits were used on the patients as an attempt to provided repeatable marker placement.
Limitations of our study include small sample size, which may lead to Type II error. A post-hoc power analysis was performed, and to correlate clinical recovery with PVF (with 80% power and 95% confidence) a sample size of 226 would be needed. For the other measures, sample sizes from 12 to 1193 would be needed. Therefore, it would take a substantial amount of time to obtain enough cases, especially when looking at a specific disease process in a specific breed of dog. There also is the potential for STA as well as inconsistent marker placement, as discussed above. We attempted to avoid STA by using the Lycra body suits. However, doing so still requires the marker to be on the skin and not the targeted osseous structure. In regard to any variability that may have occurred secondary to marker placement, we attempted to keep marker placement constant by using the same size Lycra suit for both gait trials but there is always the potential for some shifting of the body suit, and thus even a small change in the marker location.
Unfortunately, the best way to minimize STA and ensure repeatable marker placement would be to place the markers into the bony landmarks, which is unethical in the living patient.
One concern with gait analysis is how body size may affect the results. In our study, we were evaluating only 1 breed with similar body conformation. Although body weight was variable, we did not anticipate this variation to affect our results because gait data are rescaled to dimension-less values such that inertial and gravitational forces scale in proportion, and the direction of the resultant force vector does not change with body size. 46 A study assessing whether kinetic data, in particular ground reaction forces and stance time, were dependent on dog breed and body confirmation did find significant differences in force plate data among different breeds and indeed recommended that group comparisons should be made only when breeds of similar body confirmation are used. 46 In regard to the kinematic parameters, larger dogs may have had a longer stride length and duration than smaller dogs. However, for our study, the dogs were grouped together and the data averaged when comparing pre-and posttreatment and, when assessing clinical response, dogs were compared with themselves. The other parameters (eg, flexion, extension, and truncal sway) should not be affected because they were expressed in degrees. Additionally, hip drop was the difference from the maximum hip height to the minimum and therefore size should not be a factor.
During the kinematic gait analysis, we did not have any way to monitor each patient's speed, which could contribute to variability within the parameters. One way to control speed is to use a treadmill, as has been reported previously. 28 However, we chose to walk the dogs in a large, open space as it is more representative of a typical gait assessment and we felt doing so may show more gait differences. For the kinetic gait analysis, the speed could be monitored and any trial with a speed > 1.5 or < 0.5 m/s was excluded.
The type of surface also can affect a patient's gait, in particular a surface with less traction may make it more difficult for a weak or ataxic patient to walk. 47 The motion capture space consisted of rubber mats making it easy for the patients to walk. The force plate walkway was made of linoleum but the speed at which the dogs were walked did not cause any problems with ambulation. Lastly, the data collection time varied substantially in duration but did not seem to be correlated with neurologic status. Overall, the collection time for the kinetic gait analysis took 1-2 hours and the collection time for the kinematic data ranged from 45 minutes to 3 hours. We found that some dogs took longer based on their behavior when walked on a leash. In particular for the kinematic gait analysis, data collection had to be stopped and the process restarted any time a marker was dislodged, which also added a substantial amount of time to the process. Overall, the time and technique for both methods were not ideal given they took a substantial amount of time and required equipment that is not readily available and can be very expensive. More recently, a study using a pressure-sensitive walkway also found significant differences in the thoracic limbs and PVF of Doberman Pinchers with and without CSM. 30 This method of gait assessment also may be beneficial for evaluating the response of a patient with CSM to treatment because it is more commercially available than options for 3-D motion capture and less time-consuming compared to digital motion capture and force plate analysis.
In conclusion, kinetic and kinematic gait analysis detected differences in dogs with CSM before and after treatment. Unfortunately, correlation of gait analysis to clinical improvement could not be determined.
Future, larger scale studies are warranted using these and other computerized gait analysis techniques to determine if these methods can be used to evaluate response to treatment in dogs with CSM.
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